VYNE CLO has 4,007 shares withheld for taxes
VYNE Therapeutics Inc. chief legal officer Harsch Mutya reported a tax-related share disposition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VYNE Therapeutics Inc. chief legal officer Harsch Mutya reported a tax-related share disposition. On the vesting of restricted stock units, 4,007 shares of common stock were withheld by the company at $0.5975 per share to satisfy tax withholding requirements.
After this withholding, Mutya directly holds 121,898 shares of VYNE common stock. The transaction is classified as a tax-withholding disposition rather than an open-market sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 4,007 | $0.5975 | $2K |
Footnotes (1)
- F1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
tax withholding requirements financial
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VYNE (VYNE) report for Harsch Mutya?
Was the VYNE (VYNE) insider transaction an open-market sale or purchase?
What does code “F” mean in the VYNE (VYNE) Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.